Ayala Pharmaceuticals Inc

NASDAQ:AYLA   1:02:26 PM EDT
0.55
0.00 (+0.46%)
Earnings Announcements

Ayala Pharmaceuticals Reports Quarterly Basic And Diluted Net Loss Per Share Of $0.66

Published: 11/04/2022 12:15 GMT
Ayala Pharmaceuticals Inc (AYLA) - Ayala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Ayala Pharmaceuticals Inc - Qtrly Basic and Diluted Net Loss per Share of $0.66.
Revenue is expected to be $0.58 Million
Adjusted EPS is expected to be -$0.59

Next Quarter Revenue Guidance is expected to be $0.6 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.